Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study
Oncology Research · 2026
DOI: 10.32604/or.2025.072875 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Oncology Research, 2026. Verfasst von Cheng-Hsun Chuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Neoplasms, Hypoglycemic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
- Department of Emergency Medicine, School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
- Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung, 402, Taiwan.
- Department of Internal Medicine, Zuoying Armed Forces General Hospital, Kaohsiung, 813, Taiwan.
- Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
- Graduate Institute of Aerospace and Undersea Medicine, College of Biomedical Sciences, National Defense Medical University, Taipei, 114, Taiwan.
Zitieren
APA
Chuang, C. H., Tsai, P. K., Kao, S. W., Wang, Y. H., & Yeh, C. B. (2026). Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. Oncology Research. https://doi.org/10.32604/or.2025.072875
Vancouver
Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB. Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. Oncology Research. 2026. doi:10.32604/or.2025.072875
BibTeX
@article{Chuang2026,
author = {Chuang, Cheng-Hsun and Tsai, Ping-Kun and Kao, Shih-Wen and Wang, Yu-Hsun and Yeh, Chao-Bin},
title = {Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.072875}
}
EUVIMED